Treace Medical Concepts, Inc. (NasdaqGS:TMCI) entered into an asset purchase agreement to acquire certain assets of MIOS Marketing, LLC for $30 million on June 1, 2023. As reported, the purchase price is $20 million in an upfront cash payment, with up to $10 million in potential milestone payments.

Treace Medical Concepts, Inc. (NasdaqGS:TMCI) completed the acquisition of certain assets of MIOS Marketing, LLC on June 12, 2023. At closing, TMCI paid RPM-3D $20.0 million in exchange for RPM-3D?s assets used in providing pre-operative planning and patient-specific guides for the surgical correction of foot and ankle deformities. Under the APA, TMCI is obligated to pay additional consideration of up to $10.0 million in cash upon completion of certain milestones as follows: $3.5 million upon completion of certain transition services at 12 months of the closing date, $3.5 million upon completion of certain technological advancement milestones within 12 months of the closing date, and, subject to prior completion of the transition services and the technological advancement milestones, up to $3.0 million upon the issuance of certain patent claims.